Established therapies such as platelet-rich plasma (PRP) have more extensive clinical evidence and regulatory approval for certain applications
Depending on your needs, your care plan may include: Comprehensive lab testing NAD+ or glutathione IV therapy Peptide therapy Genetic insights and testing Targeted supplement recommendations Our goal is to help guide patients toward strategies that support long-term vitality and resilience through personalized care and ongoing support
Study Design Type: Phase 2, double-blind, randomized, placebo-controlled study Participants: 338 adults (BMI 30 or BMI 27 with a coexisting condition) Groups: Retatrutide 1 mg, 4 mg, 8 mg, 12 mg (different initial doses 2 or 4 mg) and placebo Duration: 48 weeks (plus 4 weeks follow-up) Administration: subcutaneous, 1x weekly Primary endpoint: percentage change in body weight at week 24 Secondary endpoints: change in weight at week 48, 5%, 10%, 15% weight reduction
It works to reduce pore size, and we often use it to calm the redness of Rosacea
87 GoyalP.KrastevaP